CONMED Corporation
CNMD
$58.29
-$0.6278-1.07%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 9.23% | -4.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.23% | -4.64% | |||
| Cost of Revenue | 7.18% | -7.19% | |||
| Gross Profit | 10.81% | -2.58% | |||
| SG&A Expenses | 3.70% | -3.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.11% | -5.34% | |||
| Operating Income | 38.87% | 0.78% | |||
| Income Before Tax | -22.70% | 50.49% | |||
| Income Tax Expenses | 32.34% | -0.89% | |||
| Earnings from Continuing Operations | -31.09% | 63.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.09% | 63.41% | |||
| EBIT | 38.87% | 0.78% | |||
| EBITDA | 24.13% | 0.77% | |||
| EPS Basic | -31.24% | 63.19% | |||
| Normalized Basic EPS | 52.10% | 2.07% | |||
| EPS Diluted | -31.19% | 63.54% | |||
| Normalized Diluted EPS | 52.26% | 2.21% | |||
| Average Basic Shares Outstanding | 0.22% | 0.14% | |||
| Average Diluted Shares Outstanding | 0.11% | 0.02% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.45% | -0.39% | |||
